We can help you get the best value for a rare and chronic disease benefits plan
Risk Quantification
We can customise our proprietary models to assess a health plan’s multi-year exposure to more than 40 rare or chronic diseases for which cures have been approved or are in the pipeline
Market Assessment
We can analyse and compare the value of existing market solutions relative to a health plan’s exposure and compare offered premiums against modelled premiums
Bespoke Solutions
We can advise benefits teams on the appropriate structure of programmes to cover cures for rare and chronic diseases - including non-insurance solutions